Ocular Immunology and Inflammation
Intravitreal bevacizumab treatment of macular edema due to optic disc vasculitis.
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
Veza se sprema u međuspremnik
Ključne riječi
Sažetak
OBJECTIVE
To report the efficacy of intravitreal bevacizumab injection in treatment of macular edema in a case of optic disc vasculitis.
METHODS
Retrospective case review.
METHODS
A patient diagnosed with macular edema due to optic disc vasculitis was treated with intravitreal bevacizumab injection.
RESULTS
One week after injection, fundus appearance dramatically improved and macular edema regressed. The patient was followed up for 1 year after injection and there was no recurrence of macular edema.
CONCLUSIONS
This case suggests that intravitreal bevacizumab treatment might be effective in the management of macular edema in patients with optic disc vasculitis.
